Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments

Abstract

Dapivirine, a non-nucleoside reverse transcriptase inhibitor, is being currently used for the development of potential anti-HIV microbicide formulations and delivery systems. A new high-performance liquid chromatography (HPLC) method with UV detection was developed for the assay of this drug in different biological matrices, namely cell lysates, receptor media from permeability experiments and homogenates of mucosal tissues. The method used a reversed-phase C18 column with a mobile phase composed of trifluoroacetic acid solution (0.1%, v/v) and acetonitrile in a gradient mode. Injection volume was 50 μL and the flow rate 1 mL/min. The total run time was 12 min and UV detection was performed at 290 nm for dapivirine and the internal standard (IS) diphenylamine. A Box-Behnken experimental design was used to study different experimental variables of the method, namely the ratio of the mobile phase components and the gradient time, and their influence in responses such as the retention factor, tailing factor, and theoretical plates for dapivirine and the IS, as well as the peak resolution between both compounds. The optimized method was further validated and its usefulness assessed for in vitro and ex vivo experiments using dapivirine or dapivirine-loaded nanoparticles. The method showed to be selective, linear, accurate and precise in the range of 0.02–1.5 μg/mL. Other chromatographic parameters, namely carry-over, lower limit of quantification (0.02 μg/mL), limit of detection (0.006 μg/mL), recovery (equal or higher than 90.7%), and sample stability at different storage conditions, were also determined and found adequate for the intended purposes. The method was successfully used for cell uptake assays and permeability studies across cell monolayers and pig genital mucosal tissues. Overall, the proposed method provides a simple, versatile and reliable way for studying the behavior of dapivirine in different biological matrices and assessing its potential as an anti-HIV microbicide drug.

Citation

das Neves, J.; Sarmento, B.; Amiji, M.; Bahia, M.F. Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments. Journal of Chromatography B (2012) 911: 76-83. [DOI: 10.1016/j.jchromb.2012.10.034]

Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments

Published 1 January 2012